{{Rsnum
|rsid=7936247
|Chromosome=11
|position=92956866
|Orientation=plus
|GMAF=0.3829
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 46.8 | 43.5 | 9.7
| HCB | 19.5 | 63.4 | 17.1
| JPT | 26.8 | 43.9 | 29.3
| YRI | 33.3 | 35.2 | 31.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 19.5 | 63.4 | 17.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23903356
  |Trait=Glycemic traits (pregnancy)
  |Title=Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies.
  |RiskAllele=T
  |Pval=3E-16
  |OR=.22
  |ORtxt=[NR] unit increase
  }}

{{PMID Auto
|PMID=19060907
|Title=Variants in MTNR1B influence fasting glucose levels.
|OA=1
}}

{{PMID Auto
|PMID=19324940
|Title=G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.
|OA=1
}}

{{PMID Auto
|PMID=20205905
|Title=Association of repeatedly measured intermediate risk factors for complex diseases with high dimensional SNP data.
|OA=1
}}

{{on chip | FTDNA}}